Related Experiment Video
Updated: Jun 12, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Radiotherapy. Hypofractionation for breast cancer--clinical implications
1Department of Radiation Oncology, UMDNJ Robert Wood Johnson Medical School, Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08901, USA. hafftybg@umdnj.edu
Nature Reviews. Clinical Oncology
|June 3, 2010
Summary
A landmark study found that a shorter radiation course (hypofractionated whole-breast irradiation) is as effective as the standard treatment for early-stage breast cancer. This offers equivalent survival, local control, and cosmetic outcomes with fewer treatments.
Area of Science:
- Oncology
- Radiation Oncology
- Clinical Trials
Background:
- Standard whole-breast irradiation involves 25 treatments over 5 weeks.
- Hypofractionated radiation therapy offers a shorter treatment schedule.
- Equivalence of outcomes between different radiation fractionation schedules requires long-term evaluation.
Purpose of the Study:
- To compare long-term outcomes of standard whole-breast irradiation versus hypofractionated whole-breast irradiation.
- To assess overall survival, local control, toxicity, and cosmetic results in early-stage, node-negative breast cancer patients.
Main Methods:
- A landmark clinical trial comparing two radiation fractionation schedules.
- Participants received either a standard course (25 treatments/5 weeks) or a hypofractionated course (16 treatments/3.5 weeks).
- Long-term results were analyzed for survival, local recurrence, treatment toxicity, and cosmetic appearance.
Main Results:
- The hypofractionated course demonstrated equivalence to the standard course.
- No significant differences were observed in overall survival between the two groups.
- Local control, toxicity profiles, and cosmetic outcomes were also comparable.
Conclusions:
- Hypofractionated whole-breast irradiation is a viable and effective alternative to standard treatment for early-stage, node-negative breast cancer.
- Shorter radiation courses can achieve similar oncologic and aesthetic results, potentially improving patient convenience.
- This finding supports the wider adoption of hypofractionated radiation in breast cancer care.
